The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact

BackgroundAmyloid-β (Aβ) accumulation is considered the earliest pathological change in Alzheimer's disease (AD). The Amyloid Imaging to Prevent Alzheimer's Disease (AMYPAD) consortium is a collaborative European framework across European Federation of Pharmaceutical Industries Associations (EFPIA),...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Lyduine E. Collij, Gill Farrar, David Valléz García, Ilona Bader, Mahnaz Shekari, Luigi Lorenzini, Hugh Pemberton, Daniele Altomare, Sandra Pla, Mery Loor, Pawel Markiewicz, Maqsood Yaqub, Christopher Buckley, Giovanni B. Frisoni, Agneta Nordberg, Pierre Payoux, Andrew Stephens, Rossella Gismondi, Pieter Jelle Visser, Lisa Ford, Mark Schmidt, Cindy Birck, Jean Georges, Anja Mett, Zuzana Walker, Mercé Boada, Alexander Drzezga, Rik Vandenberghe, Bernard Hanseeuw, Frank Jessen, Michael Schöll, Craig Ritchie, Isadora Lopes Alves, Juan Domingo Gispert, Frederik Barkhof
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2023-01-01
Seria:	Frontiers in Neurology
Hasła przedmiotowe:	amyloid positron emission tomography (PET) consortium Alzheimer's disease diagnosis prognosis
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fneur.2022.1063598/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!